메뉴 건너뛰기




Volumn 55, Issue 9, 2014, Pages 1411-1416

Head and neck PET/CT: Therapy response interpretation criteria (Hopkins criteria) - Interreader reliability, accuracy, and survival outcomes

Author keywords

Head and neck; Hopkins PET interpretation criteria; Therapy assessment

Indexed keywords

ACCURACY; ADULT; ARTICLE; CANCER PROGNOSIS; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEAR MEDICINE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PAPILLOMAVIRUS INFECTION; PREDICTIVE VALUE; PRIMARY TUMOR; PROGRESSION FREE SURVIVAL; RELIABILITY; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; TREATMENT RESPONSE; TUMOR BIOPSY; VALIDATION PROCESS; AGED; COMPUTER ASSISTED TOMOGRAPHY; HEAD AND NECK; HEAD AND NECK TUMOR; HOPKINS PET INTERPRETATION CRITERIA; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; MULTIMODAL IMAGING; POSITRON EMISSION TOMOGRAPHY; PROPORTIONAL HAZARDS MODEL; RADIOGRAPHY; RETROSPECTIVE STUDY; SCINTISCANNING; SQUAMOUS CELL CARCINOMA; THERAPY ASSESSMENT; TREATMENT OUTCOME;

EID: 84907011035     PISSN: 01615505     EISSN: 2159662X     Source Type: Journal    
DOI: 10.2967/jnumed.113.136796     Document Type: Article
Times cited : (149)

References (28)
  • 3
    • 84900489886 scopus 로고    scopus 로고
    • The clinical impact of HPV tumor status upon head and neck squamous cell carcinomas
    • Benson E, Li R, Eisele D, Fakhry C. The clinical impact of HPV tumor status upon head and neck squamous cell carcinomas. Oral Oncol. 2014;50:565-574.
    • (2014) Oral Oncol , vol.50 , pp. 565-574
    • Benson, E.1    Li, R.2    Eisele, D.3    Fakhry, C.4
  • 6
    • 84860705942 scopus 로고    scopus 로고
    • 18F-FDG metabolic tumor volume and total glycolytic activity of oral cavity and oropharyngeal squamous cell cancer: Adding value to clinical staging
    • Dibble EH, Alvarez AC, Truong MT, Mercier G, Cook EF, Subramaniam RM. 18F-FDG metabolic tumor volume and total glycolytic activity of oral cavity and oropharyngeal squamous cell cancer: adding value to clinical staging. J Nucl Med. 2012;53:709-715.
    • (2012) J Nucl Med , vol.53 , pp. 709-715
    • Dibble, E.H.1    Alvarez, A.C.2    Truong, M.T.3    Mercier, G.4    Cook, E.F.5    Subramaniam, R.M.6
  • 7
    • 80053246722 scopus 로고    scopus 로고
    • Use of 18F-FDG PET/CT as a predictive biomarker of outcome in patients with head-and-neck non-squamous cell carcinoma
    • Imsande HM, Davison JM, Truong MT, et al. Use of 18F-FDG PET/CT as a predictive biomarker of outcome in patients with head-and-neck non-squamous cell carcinoma. AJR. 2011;197:976-980.
    • (2011) AJR , vol.197 , pp. 976-980
    • Imsande, H.M.1    Davison, J.M.2    Truong, M.T.3
  • 8
    • 77951468977 scopus 로고    scopus 로고
    • Squamous cell carcinoma of the palatine tonsils: FDG standardized uptake value ratio as a biomarker to differentiate tonsillar carcinoma from physiologic uptake
    • Davison JM, Ozonoff A, Imsande HM, Grillone GA, Subramaniam RM. Squamous cell carcinoma of the palatine tonsils: FDG standardized uptake value ratio as a biomarker to differentiate tonsillar carcinoma from physiologic uptake. Radiology. 2010;255:578-585.
    • (2010) Radiology , vol.255 , pp. 578-585
    • Davison, J.M.1    Ozonoff, A.2    Imsande, H.M.3    Grillone, G.A.4    Subramaniam, R.M.5
  • 9
    • 84856084725 scopus 로고    scopus 로고
    • Parotid gland tumors: Preliminary data for the value of FDG PET/CT diagnostic parameters
    • Hadiprodjo D, Ryan T, Truong MT, Mercier G, Subramaniam RM. Parotid gland tumors: preliminary data for the value of FDG PET/CT diagnostic parameters. AJR. 2012;198:W185-W190.
    • (2012) AJR , vol.198 , pp. W185-W190
    • Hadiprodjo, D.1    Ryan, T.2    Truong, M.T.3    Mercier, G.4    Subramaniam, R.M.5
  • 10
    • 84856103634 scopus 로고    scopus 로고
    • FDG PET/CT inter-observer agreement in head and neck cancer: FDG and CT measurements of the primary tumor site
    • Jackson T, Chung M, Ozonoff A, Mercier G, Subramaniam R. FDG PET/CT inter-observer agreement in head and neck cancer: FDG and CT measurements of the primary tumor site. Nucl Med Commun. 2012;33:305-312.
    • (2012) Nucl Med Commun , vol.33 , pp. 305-312
    • Jackson, T.1    Chung, M.2    Ozonoff, A.3    Mercier, G.4    Subramaniam, R.5
  • 12
    • 84893380165 scopus 로고    scopus 로고
    • Addition of 18F-FDG PET/CT to clinical assessment predicts overall survival in HNSCC: A retrospective analysis with follow-up for 12 years
    • Paidpally V, Tahari AK, Lam S, et al. Addition of 18F-FDG PET/CT to clinical assessment predicts overall survival in HNSCC: a retrospective analysis with follow-up for 12 years. J Nucl Med. 2013;54:2039-2045.
    • (2013) J Nucl Med , vol.54 , pp. 2039-2045
    • Paidpally, V.1    Tahari, A.K.2    Lam, S.3
  • 13
    • 84902282635 scopus 로고    scopus 로고
    • Prognostic value of preoperative F-FDG PET/CT for primary head and neck squamous cell carcinoma
    • Joo YH, Yoo IR, Cho KJ, et al. Prognostic value of preoperative F-FDG PET/CT for primary head and neck squamous cell carcinoma. Eur Arch Otorhinolaryngol. 2014;271:1685-1691.
    • (2014) Eur Arch Otorhinolaryngol , vol.271 , pp. 1685-1691
    • Joo, Y.H.1    Yoo, I.R.2    Cho, K.J.3
  • 14
    • 80255126223 scopus 로고    scopus 로고
    • Diagnostic performance of post-treatment FDG PET or FDG PET/CT imaging in head and neck cancer: A systematic review and meta-analysis
    • Gupta T, Master Z, Kannan S, et al. Diagnostic performance of post-treatment FDG PET or FDG PET/CT imaging in head and neck cancer: a systematic review and meta-analysis. Eur J Nucl Med Mol Imaging. 2011;38:2083-2095.
    • (2011) Eur J Nucl Med Mol Imaging , vol.38 , pp. 2083-2095
    • Gupta, T.1    Master, Z.2    Kannan, S.3
  • 15
    • 84868005520 scopus 로고    scopus 로고
    • The role of positron emission tomography/CT imaging in head and neck cancer patients after radical chemoradiotherapy
    • Sherriff JM, Ogunremi B, Colley S, Sanghera P, Hartley A. The role of positron emission tomography/CT imaging in head and neck cancer patients after radical chemoradiotherapy. Br J Radiol. 2012;85:e1120-e1126.
    • (2012) Br J Radiol , vol.85 , pp. e1120-e1126
    • Sherriff, J.M.1    Ogunremi, B.2    Colley, S.3    Sanghera, P.4    Hartley, A.5
  • 17
    • 84855826127 scopus 로고    scopus 로고
    • The role of computed tomography in the management of the neck after chemoradiotherapy in patients with head-and-neck cancer
    • Clavel S, Charron MP, Belair M, et al. The role of computed tomography in the management of the neck after chemoradiotherapy in patients with head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2012;82:567-573.
    • (2012) Int J Radiat Oncol Biol Phys , vol.82 , pp. 567-573
    • Clavel, S.1    Charron, M.P.2    Belair, M.3
  • 18
    • 33847252057 scopus 로고    scopus 로고
    • Detection of head and neck squamous cell carcinoma with diffusion weighted MRI after (chemo)radiotherapy: Correlation between radiologic and histopathologic findings
    • Vandecaveye V, De Keyzer F, Nuyts S, et al. Detection of head and neck squamous cell carcinoma with diffusion weighted MRI after (chemo)radiotherapy: correlation between radiologic and histopathologic findings. Int J Radiat Oncol Biol Phys. 2007;67:960-971.
    • (2007) Int J Radiat Oncol Biol Phys , vol.67 , pp. 960-971
    • Vandecaveye, V.1    De Keyzer, F.2    Nuyts, S.3
  • 19
    • 80052282829 scopus 로고    scopus 로고
    • Neck dissection can be avoided after sequential chemoradiotherapy and negative post-treatment positron emission tomography-computed tomography in N2 head and neck squamous cell carcinoma
    • Loo SW, Geropantas K, Beadsmoore C, Montgomery PQ, Martin WM, Roques TW. Neck dissection can be avoided after sequential chemoradiotherapy and negative post-treatment positron emission tomography-computed tomography in N2 head and neck squamous cell carcinoma. Clin Oncol (R Coll Radiol). 2011;23:512-517.
    • (2011) Clin Oncol (R Coll Radiol) , vol.23 , pp. 512-517
    • Loo, S.W.1    Geropantas, K.2    Beadsmoore, C.3    Montgomery, P.Q.4    Martin, W.M.5    Roques, T.W.6
  • 20
    • 40349089017 scopus 로고    scopus 로고
    • Deferring planned neck dissection following chemoradiation for stage IV head and neck cancer: The utility of PETCT
    • Nayak JV, Walvekar RR, Andrade RS, et al. Deferring planned neck dissection following chemoradiation for stage IV head and neck cancer: the utility of PETCT. Laryngoscope. 2007;117:2129-2134.
    • (2007) Laryngoscope , vol.117 , pp. 2129-2134
    • Nayak, J.V.1    Walvekar, R.R.2    Andrade, R.S.3
  • 21
    • 44949123699 scopus 로고    scopus 로고
    • Current status of FDG-PET for head and neck cancer
    • Wong RJ. Current status of FDG-PET for head and neck cancer. J Surg Oncol.2008;97:649-652.
    • (2008) J Surg Oncol , vol.97 , pp. 649-652
    • Wong, R.J.1
  • 22
    • 66349107938 scopus 로고    scopus 로고
    • 18F]fluorodeoxyglucose positron emission tomography and computed tomography assessment of radiation response in head and neck cancer
    • Moeller BJ, Rana V, Cannon BA, et al. Prospective risk-adjusted [18F]fluorodeoxyglucose positron emission tomography and computed tomography assessment of radiation response in head and neck cancer. J Clin Oncol. 2009;27:2509-2515.
    • (2009) J Clin Oncol , vol.27 , pp. 2509-2515
    • Moeller, B.J.1    Rana, V.2    Cannon, B.A.3
  • 23
    • 73449130212 scopus 로고    scopus 로고
    • Revisiting the role of positron-emission tomography/computed tomography in determining the need for planned neck dissection following chemoradiation for advanced head and neck cancer
    • Gourin CG, Boyce BJ, Williams HT, Herdman AV, Bilodeau PA, Coleman TA. Revisiting the role of positron-emission tomography/computed tomography in determining the need for planned neck dissection following chemoradiation for advanced head and neck cancer. Laryngoscope. 2009;119:2150-2155.
    • (2009) Laryngoscope , vol.119 , pp. 2150-2155
    • Gourin, C.G.1    Boyce, B.J.2    Williams, H.T.3    Herdman, A.V.4    Bilodeau, P.A.5    Coleman, T.A.6
  • 25
    • 79952114063 scopus 로고    scopus 로고
    • Concordance between four European centres of PET reporting criteria designed for use in multicentre trials in Hodgkin lymphoma
    • Barrington SF, Qian W, Somer EJ, et al. Concordance between four European centres of PET reporting criteria designed for use in multicentre trials in Hodgkin lymphoma. Eur J Nucl Med Mol Imaging. 2010;37:1824-1833.
    • (2010) Eur J Nucl Med Mol Imaging , vol.37 , pp. 1824-1833
    • Barrington, S.F.1    Qian, W.2    Somer, E.J.3
  • 26
    • 84877115529 scopus 로고    scopus 로고
    • International validation study for interim PET in ABVD-treated, advanced-stage Hodgkin lymphoma: Interpretation criteria and concordance rate among reviewers
    • Biggi A, Gallamini A, Chauvie S, et al. International validation study for interim PET in ABVD-treated, advanced-stage Hodgkin lymphoma: interpretation criteria and concordance rate among reviewers. J Nucl Med. 2013;54:683-690.
    • (2013) J Nucl Med , vol.54 , pp. 683-690
    • Biggi, A.1    Gallamini, A.2    Chauvie, S.3
  • 27
    • 25444485679 scopus 로고    scopus 로고
    • Total shoulder arthroplasty: Long-term survivorship, functional outcome, and quality of life
    • Deshmukh AV, Koris M, Zurakowski D, Thornhill TS, et al. Total shoulder arthroplasty: long-term survivorship, functional outcome, and quality of life. J Shoulder Elbow Surg. 2005;14:471-479.
    • (2005) J Shoulder Elbow Surg , vol.14 , pp. 471-479
    • Deshmukh, A.V.1    Koris, M.2    Zurakowski, D.3    Thornhill, T.S.4
  • 28
    • 0033044992 scopus 로고    scopus 로고
    • Value of negative dobutamine stress echocardiography in predicting long-term cardiac events
    • Dhond MR, Donnell K, Singh S, et al. Value of negative dobutamine stress echocardiography in predicting long-term cardiac events. J Am Soc Echocardiogr. 1999;12:471-475.
    • (1999) J Am Soc Echocardiogr , vol.12 , pp. 471-475
    • Dhond, M.R.1    Donnell, K.2    Singh, S.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.